Researchers have suggested the cannabis derived cannabinoid Cannabidiol (CBD) may help treat patients for COVID-19. CBD has shown in the past it can have anti-inflammatory properties to help patients with COVID-19 to reduce inflammation in the body. We are actively following this to take advantage of this for our investors.
Cannabidiol, or CBD, may help reduce the cytokine storm and excessive lung inflammation that is killing many patients with COVID-19, researchers say.
Our laboratory studies indicate pure CBD can help the lungs recover from the overwhelming inflammation, or cytokine storm, caused by the COVID-19 virus, and restore healthier oxygen levels in the body, says co-author Dr. Jack Yu, physician-scientist and chief of pediatric plastic surgery at MCG.
We remain very optimistic about the future of global cannabis sector in the coming years as better leadership at companies will help drive success as new markets open. 2021 could be a breakout year for cannabis if we get some momentum for a federal reschedule of cannabis.
